Literature DB >> 9577413

Animal models of heterotopic ossification.

J P O'Connor1.   

Abstract

Heterotopic ossification is often a severe clinical complication of joint arthroplasty, neurologic trauma, and muscle injury. In rare genetic disorders, such as fibrodysplasia ossificans progressiva, heterotopic ossification can be crippling and often leads to premature death. Reliable animal models of heterotopic ossifications that mimic pathologies seen in man would be invaluable for the development of new treatments to combat heterotopic ossification. Various methods used to induce heterotopic ossification in animals including the use of bone morphogenetic proteins, urinary tract epithelia, and transformed cell lines are described. Genetic animal models of heterotopic ossification and various miscellaneous examples of heterotopic ossification in animals are described. Finally, the use of transgenic mice to manipulate bone morphogenetic protein expression is discussed as a possible future animal model of heterotopic ossification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577413

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification.

Authors:  Michael N Wosczyna; Arpita A Biswas; Catherine A Cogswell; David J Goldhamer
Journal:  J Bone Miner Res       Date:  2012-05       Impact factor: 6.741

Review 2.  Retinoid roles and action in skeletal development and growth provide the rationale for an ongoing heterotopic ossification prevention trial.

Authors:  Maurizio Pacifici
Journal:  Bone       Date:  2017-08-19       Impact factor: 4.398

3.  Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.

Authors:  Sayantani Sinha; Kenta Uchibe; Yu Usami; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Bone       Date:  2016-02-15       Impact factor: 4.398

4.  Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification.

Authors:  Lixin Kan; Yijie Liu; Tammy L McGuire; Diana M Palila Berger; Rajeshwar B Awatramani; Susan M Dymecki; John A Kessler
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

5.  Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

Authors:  Kengo Shimono; Wei-En Tung; Christine Macolino; Amber Hsu-Tsai Chi; Johanna H Didizian; Christina Mundy; Roshantha A Chandraratna; Yuji Mishina; Motomi Enomoto-Iwamoto; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

6.  Experimental model of heterotopic ossification in Wistar rats.

Authors:  T G G Zotz; J B de Paula; A D L Moser
Journal:  Braz J Med Biol Res       Date:  2012-03-15       Impact factor: 2.590

7.  Characterization of Cells Isolated from Genetic and Trauma-Induced Heterotopic Ossification.

Authors:  Shailesh Agarwal; James Drake; Ammar T Qureshi; Shawn Loder; Shuli Li; Kay Shigemori; Jonathan Peterson; David Cholok; Jonathan A Forsberg; Yuji Mishina; Thomas A Davis; Benjamin Levi
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

8.  Validation of a Radiography-Based Quantification Designed to Longitudinally Monitor Soft Tissue Calcification in Skeletal Muscle.

Authors:  Stephanie N Moore; Gregory D Hawley; Emily N Smith; Nicholas A Mignemi; Rivka C Ihejirika; Masato Yuasa; Justin M M Cates; Xulei Liu; Jonathan G Schoenecker
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

9.  Prophylaxis of heterotopic ossification - an updated review.

Authors:  Evan O Baird; Qian K Kang
Journal:  J Orthop Surg Res       Date:  2009-04-20       Impact factor: 2.359

Review 10.  NSAID therapy effects on healing of bone, tendon, and the enthesis.

Authors:  Bailey Su; J Patrick O'Connor
Journal:  J Appl Physiol (1985)       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.